Home Creyon Bio

Creyon Bio

In operation
Series A
RNA Drug Developer

Basic Information

Creyon Bio, led by co-founder, CEO and President Chris Hart and co-founder and Chief Scientific Officer Dr. Swagatam Mukhopadhyay, is a drug development company focused on developing RNA-based therapeutics and their components. Creyon Bio creates proprietary, purpose-built datasets to inform machine learning models, rapidly identifying design rules and engineering principles for safe and effective OBM.
Creyon Bio
SanDiego,California,United States of America
unclear
January 01, 2019
info@creyonbio.com